Free Trial

Edgestream Partners L.P. Acquires New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background
Remove Ads

Edgestream Partners L.P. acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 298,810 shares of the company's stock, valued at approximately $6,932,000. Edgestream Partners L.P. owned approximately 0.18% of Option Care Health as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Westfield Capital Management Co. LP raised its position in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after acquiring an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. raised its holdings in shares of Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company's stock worth $1,559,000 after purchasing an additional 25,905 shares in the last quarter. Graypoint LLC acquired a new stake in Option Care Health during the fourth quarter valued at approximately $1,161,000. Victory Capital Management Inc. lifted its stake in Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock valued at $50,756,000 after purchasing an additional 1,585,818 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Option Care Health during the fourth quarter worth approximately $327,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Barrington Research lifted their target price on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. UBS Group initiated coverage on Option Care Health in a report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price objective on the stock. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities restated a "market outperform" rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $33.00.

Remove Ads

Get Our Latest Analysis on Option Care Health

Option Care Health Stock Up 0.1 %

Option Care Health stock traded up $0.04 during trading hours on Tuesday, hitting $33.42. The company had a trading volume of 1,993,963 shares, compared to its average volume of 1,603,488. The firm's fifty day moving average is $30.04 and its 200-day moving average is $28.17. The firm has a market capitalization of $5.52 billion, a P/E ratio of 28.08, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.85. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Company Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads